Harper Molly (CIK 1871470) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-30). Recent activity: Buy CPRX (1,334 shares), Buy CPRX (20,000 shares), Sell CPRX (15,527 shares), Sell CPRX (4,473 shares), Sell CPRX (6,746 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-30 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 1,334 | $0 |
| 2025-12-16 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 20,000 | $115,600 |
| 2025-12-16 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Sell | 15,527 | $360,226 |
| 2025-12-16 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Sell | 4,473 | $106,144 |
| 2025-12-16 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Sell | 6,746 | $155,563 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 1,413 | $0 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 947 | $0 |
| 2025-02-19 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 4,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-30